These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 7795118

  • 1. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
    Calvo C, López E, Barrio E, Espejo J, Ruiz M, Vega A.
    An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 5. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J, Solar M.
    Blood Press; 2009 Apr; 18(1-2):74-7. PubMed ID: 19353415
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of the efficacy and tolerance of doxazosin vs. enalapril inaged patients with light to moderate arterial hypertension].
    Puddu P, Gallucci M, Curnis A, Pupita F, Ansuini R, Malacco E.
    Clin Ter; 1995 Dec; 146(12):801-10. PubMed ID: 8681500
    [Abstract] [Full Text] [Related]

  • 7. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
    Hitzenberger G, Ganzinger U.
    Wien Klin Wochenschr; 1993 Dec; 105(13):371-6. PubMed ID: 8351927
    [Abstract] [Full Text] [Related]

  • 8. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M, Chotkowska E, Peczkowska M, Sawicki M, Janaszek-Sitkowska H, Wiernikowska-Wegorek I, Galewicz A, Cybulska I.
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [Abstract] [Full Text] [Related]

  • 9. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
    de Alvaro F, Hernández-Presa MA, ASOCIA Study.
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
    [Abstract] [Full Text] [Related]

  • 10. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
    Chung BH, Hong SJ, Lee MS.
    Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
    [Abstract] [Full Text] [Related]

  • 11. Doxazosin in hypertension: results of a general practice study in 4809 patients.
    Langdon CG, Packard RS.
    Br J Clin Pract; 1994 Feb; 48(6):293-8. PubMed ID: 7848789
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of essential arterial hypertension with hypercholesterolemia. Effects of an alpha-adrenergic blocker and an inhibitor of the angiotensin converting enzyme].
    Fernández Pinilla C, Luque Otero M, Martell Claros N, Alcázar de la Osa JM, Rodicio Díaz JL, Ruilope Urioste LM.
    Med Clin (Barc); 1993 Jun 26; 101(5):168-71. PubMed ID: 8332009
    [Abstract] [Full Text] [Related]

  • 13. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T, Gomi T, Shibuya Y, Shinozaki S, Suzuki Y, Matsuda N.
    Hypertens Res; 2007 Nov 26; 30(11):1097-105. PubMed ID: 18250559
    [Abstract] [Full Text] [Related]

  • 14. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K, Ikarashi T.
    Clin Exp Hypertens; 2005 May 26; 27(4):369-76. PubMed ID: 15921073
    [Abstract] [Full Text] [Related]

  • 15. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C, Gil-Extremera B, Gomez-Fernández P, Masramon X, Pueyo C, Armada B.
    Int J Cardiol; 2005 May 11; 101(1):97-104. PubMed ID: 15860390
    [Abstract] [Full Text] [Related]

  • 16. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study.
    Kario K, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K, Japan Morning Surge-1 (JMS-1) Study Group.
    J Hypertens; 2008 Jun 11; 26(6):1257-65. PubMed ID: 18475166
    [Abstract] [Full Text] [Related]

  • 17. [Doxazosin for the treatment of arterial hypertension].
    Mozzato MG, Semplicini A, Serena L, Valle R, Casolino P, Buzzaccarini F, Rubino N, Giusto M, Pessina AC.
    Cardiologia; 1990 Nov 11; 35(11):931-6. PubMed ID: 2151571
    [Abstract] [Full Text] [Related]

  • 18. [Effects of monotherapy with an alpha1-adrenoblocker doxazosin and its combination with beta1-adrenoblocker atenolol on hemodynamics, reversible myocardial ischemia in postmyocardial infarction patients with arterial hypertension].
    Tepliakov AT, Gavrilova NV, Garganeeva AA.
    Klin Med (Mosk); 2003 Nov 11; 81(11):17-21. PubMed ID: 14689703
    [Abstract] [Full Text] [Related]

  • 19. [Antihypertensive therapy with doxazosin in patients with non-insulin-dependent diabetes mellitus].
    Lazebnik LB, Melichenko SB, Serebrov AN.
    Ter Arkh; 1998 Nov 11; 70(2):50-4. PubMed ID: 9551574
    [Abstract] [Full Text] [Related]

  • 20. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.
    Diabet Med; 2005 Oct 11; 22(10):1394-400. PubMed ID: 16176202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.